ArticleBMJ open2025

Tirzepatide for the treatment of adults living with concurrent type 1 diabetes and overweight or obesity (TZP-T1D): a double-blind, placebo-matched randomised controlled trial protocol.

Amanda R Purcell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.